Alnylam raises $359.4M in follow-on

RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) raised $359.4 million on May 24 through the sale of 5 million shares at $71.87 in a follow-on underwritten by Barclays Capital....